Global Vaccine Cold Chain Logistics Market Size is valued at USD 3.5 Billion in 2024 and is predicted to reach USD 5.9 Billion by the year 2034 at a 5.3% CAGR during the forecast period for 2025-2034.
Technological advancements have helped in the development of vaccines in recent years. Vaccines are widely used to control infectious diseases as one of the prevention strategies to maintain the sustainable health of the population. The current covid-19 outbreak has significantly created a huge demand for temperature-controlled storage for vaccines across the globe.
Several drug candidates are being developed and tested to treat COVID-19 infection. There are currently over 250 vaccines across seven platforms being designed and trialed to treat COVID-19 infection. Few candidates are about to receive government approval or at the end of late-stage clinical trials of the Covid-19 vaccine in several countries. However, the next challenge that awaits is the cold chain logistics for vaccine distribution in various countries with different weather conditions. The proper cold storage is critical in the case of covid-19 vaccines as they require temperature-controlled storage and distribution to maintain their efficacy and other properties.
As per the white paper published by DHL in December 2020, around 200,000 pallet shipments and 15 million deliveries in cooling boxes, as well as 15,000 flights, will be required across various supply chain set-ups in the next two years to provide global coverage. Thus, the stable, safe, and IT-enabled supply chain framework and durable physical logistics infrastructure would help vaccine distribution globally.
In addition to the Covid-19 vaccine development, breakthroughs in cancer research efforts, growing pharmaceutical industry, augmented investment in R&D for vaccine development, and increased number of refrigerated warehouses are expected to boost the vaccine cold chain logistics market during the forecast period.
The Global Vaccine Cold Chain Logistics market is categorized based on services, packaging methods, mode of transportation, holding temperature range, and container and region.
Market Segmentation
On the basis of services, the market is segmented into storage, packaging, transportation. Based on packaging methods, the market is segmented into dry ice, liquid nitrogen, gel packs. on the basis of mode of transportation, the market is segregated into ground, air, and ocean. Based on the holding temperature range, the market is classified into vaccines requiring refrigerated temperature, vaccines requiring frozen temperature, vaccines requiring cryogenic temperature. On the basis of the containers, the market is segmented into active containers, passive containers.
Based on the region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among all, North America is expected to dominate the market during the forecast period.
Competitive Landscape
Some Of The Key Players In The Vaccine Cold Chain Logistics Market:
- Cryoport
- DHL Express
- GAC
- Lynden International Logistics
- PAREXEL
- United Parcel Service
- Yusen Logistics
- DB Schenker
- CEVA Logistics
- Q1 Scientific
- AmeriCold Logistics LLC
- FedEx Corporation
- Sofrigam
- Sartorius AG
- Intelsius
- Envirotainer
- Coldman Logistics
- B Medical Systems
- CSafe
- Other Prominent Player
Recent Developments
- In August 2023, UPS Healthcare expanded its UPS Premier service to India, another step in upgrading service and technology to satisfy the needs of time- and temperature-sensitive healthcare goods. Indian clients will get UPS Premier Gold service benefits like ‘first-in, first-off’ prioritization, built-in service recovery features in the UPS global network, and 24/7 control tower monitoring.
- In September 2022, Cryoport Systems established a strategic partnership with BioLife Plasma Services, a branch of the renowned biopharmaceutical company Takeda, to provide reliable and superior cellular starting material for manufacturing critical cellular medicines. The two companies will initially create a novel operational framework in Houston, Texas, to establish comprehensive collection, processing, and distribution services. This would involve merging the local donation facilities of BioLife Plasma Services with Cryoport's newly established global supply chain centre.
The Vaccine Cold Chain Logistics Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 3.5 Billion |
|
Revenue Forecast In 2034 |
USD 5.9 Billion |
|
Growth Rate CAGR |
CAGR of 5.3% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Mn,and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Service, By Packaging Method, By Mode of Transportation, By Holding Temperature Range, By Container |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Cryoport, DHL Express, GAC, Lynden International Logistics, PAREXEL, United Parcel Service, Yusen Logistics, DB Schenker, CEVA Logistics, Q1 Scientific, AmeriCold Logistics LLC, FedEx Corporation, Sofrigam, Sartorius AG, Intelsius, Envirotainer, Coldman Logistics, B Medical Systems, CSafe, Other Prominent Player |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
